ML-154
 | |
| Clinical data | |
|---|---|
| ATC code | none |
| Identifiers | |
| |
| CAS Number | 1345964-89-7 |
| PubChem (CID) | 46930969 |
| ChemSpider | 26360842 |
| Chemical and physical data | |
| Formula | C29H26BrN2PS |
| Molar mass | 545.472 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
ML-154 (NCGC-84) is a drug which acts as a selective, non-peptide antagonist at the neuropeptide S receptor NPSR.[1] In animal studies it decreases self-administration of alcohol in addicted rats, and lowers motivation for alcohol rewards, suggesting a potential application for NPS antagonists in the treatment of alcoholism.[2]
See also
References
- ↑ Patnaik S, Marugan JJ, Liu K, Zheng W, Southall N, Dehdashti SJ, Thorsell A, Heilig M, Bell L, Zook M, Eskay B, Brimacombe KR, Austin CP. Structure-activity relationship of imidazopyridinium analogues as antagonists of neuropeptide S receptor. J Med Chem. 2013 Nov 27;56(22):9045-56. doi: 10.1021/jm400904m PMID 24171469
- ↑ Thorsell A, Tapocik JD, Liu K, Zook M, Bell L, Flanigan M, Patnaik S, Marugan J, Damadzic R, Dehdashti SJ, Schwandt ML, Southall N, Austin CP, Eskay R, Ciccocioppo R, Zheng W, Heilig M. A novel brain penetrant NPS receptor antagonist, NCGC00185684, blocks alcohol-induced ERK-phosphorylation in the central amygdala and decreases operant alcohol self-administration in rats. J Neurosci. 2013 Jun 12;33(24):10132-42. doi: 10.1523/JNEUROSCI.4742-12.2013 PMID 23761908
This article is issued from Wikipedia - version of the 10/21/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.